Study at a glance
- Design
- Uncontrolled, two-participant safety pilot
- Who or what was studied
- Two adults aged 58 and 68 who had previously received intravenous BPC-157
Neither participant reported side effects during two infusion days and follow-up through the next day.
Key limitation: Two previously exposed adults followed for three days cannot establish general, rare-event or long-term safety, and the study did not test injury recovery.
Preview sources: PDF pages 1; PDF pages 2; PDF pages 3; PDF pages 4; PDF pages 5
This is an AI-assisted editorial draft. Unresolved questions and source checks are identified in the review; it has not received independent methodological or clinical approval.
Log in to read the full review
Read the methods, numerical findings, harms, limitations, and source locations with a free PepsAnon account.
Log in to continueNo subscription or payment is required.